KN-027

N/A

Report date: 2024/01/10 15:13:48

Base Information

Drug NameKN-027
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionPlatelet-derived growth factor receptor inhibitorsVascular endothelial growth factor receptor antagonists
TargetsPlatelet-derived growth factor receptorVascular endothelial growth factor receptor
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesAlphamab Oncology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJiangsu Alphamab Biopharmaceuticals Co Ltd
Active IndicationsN/A
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A